Abstract:Aim: Estradiol treatment regulates estrogen receptor (ER) level in normal rat liver. However, little information is available concerning the role of estrogen in regulating liver ER in hepatic fibrosis in rats. The present study was conducted to determine whether estradiol treatment in CCl4-induced liver fibrosis of female and ovariectomized rats altered liver ERalpha and its mRNA expression, and to investigate the possible mechanisms.Methods: Seventy female rats were divided into seven groups with ten rats in each. The ovariectomy groups were initiated with ovariectomies and the sham operation groups were initiated with just sham operations. The CCl4 toxic fibrosis groups received 400 mL/L CCl4 subcutaneously at a dose of 2 mL/kg twice weekly. Estrogen groups were treated subcutaneously with estradiol 1 mg/kg, the normal control group and an ovariectomy group received injection of peanut oil vehicle twice weekly. At the end of 8 weeks, all the rats were killed to detect their serum and hepatic indicators, their hepatic collagen content, and liver ER and ER mRNA expression.Results: Estradiol treatment in both ovariectomy and sham ovariectomy groups reduced liver levels of ALT (from 658+/-220 nkat/L to 311+/-146 nkat/L and 540+/-252 nkat/L to 314+/-163 nkat/L, P<0.05) and AST (from 697 +/- 240 nkat/L to 321 121 nkat/L and 631 268 nkat/L to 302 153 nkat/L, P<0.05), increased serum nitric oxide (NO) level (from 53.7+/-17.1 mumol/L to 93.3+/-24.2 mumol/L and 55.3+/-23.1 mumol/L to 87.5+/-23.6 mumol/L, P<0.05) and hepatic nitric oxide synthase (NOS) activity (from 1.73 +/- 0.71 KU/g to 2.49 +/- 1.20 KU/g and 1.65 +/- 0.46 KU/g to 2.68 +/- 1.17 KU/g, P<0.05), diminished the accumulation of hepatic collagen, decreased centrolobular necrotic areas as well as the inflammatory reaction in rats subjected to CCl4. The positive signal of ER and ER mRNA distributed in parenchymal and non-parenchymal hepatic cells, especially near the hepatic centrolobular and periportal areas. Ovariectomy decreased ER level (from 10.2+/-3.2 to 4.3+/-1.3) and ER mRNA expression (from 12.8+/-2.1 to 10.9+/-1.3) significantly (P<0.05). Hepatic ER and ER mRNA concentrations were elevated after treatment with estradiol in both ovariectomy (15.8 +/- 2.4, 20.8 +/- 3.1) and sham ovariectomy (18.7 +/- 3.8, 23.1 +/- 3.7) fibrotic, groups (P<0.05).Conclusion: The increase in hepatic ER and mRNA expression may be part of the molecular mechanisms underlying the suppressive effect of estradiol on liver fibrosis induced by CCl4 administration.

Protective Effects of Physiological Doses of Estrogen During Hepatocarcinogenesis Induced by Diethylnitrosamine and N-nitrosomorpholine.

Protective Effects of Physiological Doses of Estrogen During Hepatocarcinogenesis in a Rat Model

Estrogen Suppresses Metastasis in Rat Hepatocellular Carcinoma through Decreasing Interleukin-6 and Hepatocyte Growth Factor Expression

Estrogen Attenuates Diethylnitrosamine-Induced Hepatocellular Carcinoma in Female Rats via Modulation of Estrogen Receptor/FASN/CD36/IL-6 Axis

Effect of gonadectomy on carcinogenesis and development of hepatocellular carcinoma induced by chemical substances in rat model

Estrogen Inhibits Colon Polyp Formation By Reducing Angiogenesis In A Carcinogen-Induced Rat Model

Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing

Role of estrogen in hepatocellular carcinoma: is inflammation the key?

Estrogen alleviates liver fibrosis and restores metabolic homeostasis in ovariectomy-induced liver injury and carbon tetrachloride (CCl4) exposure

Effects of Estradiol on Liver Estrogen Receptor-Alpha and Its Mrna Expression in Hepatic Fibrosis in Rats

Suppressive Effects of 17Beta-Estradiol on Hepatic Fibrosis in CCl4-induced Rat Model.

Switching (overtargeting) of estrogen effects and its potential role in hormonal carcinogenesis

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

Oestrogen Attenuates Tumour Progression in Hepatocellular Carcinoma

Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome

Protective effect of estradiol on hepatocytic oxidative damage.

Estrogen suppresses hepatocellular carcinoma cells through ER β -mediated upregulation of the NLRP3 inflammasome

Estrogen Inhibits DMH-induced Tumor Formation by Regulating COX-2 Mediated Angiogenesis

Protective effects of Althaea officinalis L. extract against N‐diethylnitrosamine‐induced hepatocellular carcinoma in male Wistar rats through antioxidative, anti‐inflammatory, mitochondrial apoptosis and PI3K/Akt/mTOR signaling pathways

A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2

Oxidant stress induction and signalling in xenografted (human breast cancer-tissues) plus estradiol treated or N-ethyl-N-nitrosourea treated female rats via altered estrogen sulfotransferase (rSULT1E1) expressions and SOD1/catalase regulations